SYBX Quote, Trading Chart, Synlogic Inc.
home / stock / sybx / sybx quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-01-26 | 3.99 | 4.03 | 4.09 | 3.99 | 317,720 |
| 2021-01-25 | 4.055 | 4.09 | 4.1352 | 3.98 | 489,611 |
| 2021-01-22 | 4.15 | 4.09 | 4.25 | 3.95 | 520,636 |
| 2021-01-21 | 3.89 | 4.27 | 4.3 | 3.75 | 1,013,773 |
| 2021-01-20 | 3.85 | 3.84 | 3.9 | 3.55 | 846,562 |
| 2021-01-19 | 3.51 | 3.81 | 3.86 | 3.5 | 1,224,100 |
| 2021-01-18 | 3.3 | 3.52 | 3.565 | 3.16 | 1,551,376 |
| 2021-01-15 | 3.3 | 3.52 | 3.565 | 3.16 | 1,542,011 |
| 2021-01-14 | 3.07 | 3.26 | 3.3 | 2.95 | 2,319,866 |
| 2021-01-13 | 2.99 | 3.1999 | 3.74 | 2.81 | 37,044,158 |
| 2021-01-12 | 2.43 | 2.4 | 2.485 | 2.37 | 524,923 |
| 2021-01-11 | 2.4 | 2.41 | 2.43 | 2.34 | 197,612 |
| 2021-01-08 | 2.31 | 2.37 | 2.44 | 2.3002 | 393,364 |
| 2021-01-07 | 2.25 | 2.38 | 2.38 | 2.25 | 502,165 |
| 2021-01-06 | 2.29 | 2.25 | 2.365 | 2.23 | 536,470 |
| 2021-01-05 | 2.25 | 2.24 | 2.3 | 2.19 | 624,456 |
| 2021-01-04 | 2.19 | 2.2 | 2.26 | 2.15 | 431,879 |
| 2021-01-01 | 2.19 | 2.16 | 2.25 | 2.16 | 307,732 |
| 2020-12-31 | 2.19 | 2.16 | 2.25 | 2.16 | 302,461 |
| 2020-12-30 | 2.11 | 2.21 | 2.29 | 2.08 | 363,312 |
News, Short Squeeze, Breakout and More Instantly...
-
Synlogic Outlines Upcoming Clinical Milestones - Clinical proof of concept data in 2021 anticipated across multiple programs - PR Newswire CAMBRIDGE, Mass. , Jan. 11, 2021 /PRNewswire/ -- Synlogic, Inc. ( Nasdaq: SYBX ), a clinical stage company bringing ...
-
Synlogic Announces Advancement of SYNB1891 to Combination Arm Dosing with PD-L1 Checkpoint Inhibitor in the on-going Phase 1 Study for the Treatment of Solid Tumors and Lymphoma CAMBRIDGE, Mass. , Dec. 14, 2020 /PRNewswire/ -- Synlogic, Inc. ( Nasdaq: SYBX )...
-
Synlogic Appoints Michael Heffernan to its Board of Directors CAMBRIDGE, Mass. , Dec. 9, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the appointm...